ABSTRACT

Financing Vaccines for Global Health Security   [open pdf - 0B]

From the Abstract: "Recent outbreaks of infectious pathogens such as Zika, Ebola, and COVID-19 [coronavirus disease 2019] have underscored the need for the dependable availability of vaccines against emerging infectious diseases (EIDs). The cost and risk of R&D [research & development] programs and uniquely unpredictable demand for EID vaccines have discouraged vaccine developers, and government and nonprofit agencies have been unable to provide timely or sufficient incentives for their development and sustained supply. We analyze the economic returns of a portfolio of EID vaccine assets, and find that under realistic financing assumptions, the expected returns are significantly negative, implying that the private sector is unlikely to address this need without public-sector intervention. We have sized the financing deficit for this portfolio and analyze several potential solutions, including price increases, enhanced public-private partnerships, and subscription models through which individuals would pay annual fees to obtain access to a portfolio of vaccines in the event of an outbreak."

Report Number:
NBER Working Paper No. 27212; National Bureau of Economic Research Working Paper No. 27212
Author:
Publisher:
Date:
2020-05
Series:
Copyright:
2020 Jonathan T. Vu, Benjamin K. Kaplan, Shomesh Chaudhuri, Monique K. Mansoura, and Andrew W. Lo
Retrieved From:
National Bureau of Economic Research: https://www.nber.org/
Media Type:
application/pdf
URL:
Help with citations